Background: Cigarette smoking is the cardinal cause of chronic obstructive pulmonary disease (COPD), but only a relatively small percentage of smokers are developing clinically overt disease, suggesting, therefore, that other risk factors than smoking are involved. Several studies have shown that the bronchodilator response (BR) is related to the progress of COPD, as assessed by the fall in forced expiratory volume in 1 s (FEV(1)). However, the relationship between BR and fall in FEV(1), is a disputed one.
Objective: To assess the relationship between BR and fall in FEV(1) in a group of long-term smokers and ex-smokers who were 60 years old on the average.
Methods: Questionnaire, spirographic tests and BR were assessed in 56 smokers and ex-smokers of mean age 62.5 +/- (SD) 2.7 years at the end of a 13-year follow-up period. BR was expressed as a percentage change of the prebronchodilator value ('% initial') and as a percentage change of predicted value ('% predicted').
Results: The FEV(1)/VC vital capacity was 68.9 +/- 7.6% at the start and 64.5 +/- 11.3% at the end of the study. The average fall in FEV(1) over 13 years was 26 +/- 25 ml/year. The FEV(1) increased after albuterol on the average with 5.9 +/- 6.6%, 4.5 +/- 3.9% of predicted, and the vital capacity with 2.5 +/- 6.5%, 2.3 +/- 6.4% of predicted. BR and fall in FEV(1) were correlated: the greater the BR, the more rapid the fall in FEV(1) (r = 0.4 and p < 0.01 for FEV(1)% and r = 0.3 and p < 0.05 for FEV(1) predicted). However, when adjusting for prebronchodilator FEV(1), the BR was no more related to the fall in FEV(1) (r = 0.15, p > 0.05).
Conclusions: In long-term smokers and ex-smokers, the BR measured at the end of the follow-up period was correlated with the fall in FEV(1). However, after adjusting for prebronchodilator FEV(1) values, BR was no more related to the decline in FEV(1). The BR appears not to be associated with the development of COPD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000029448 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Midterm Effects of SARS-CoV-2 on Respiratory Function in Judokas With and Without Exercise-Induced Bronchoconstriction: A Retrospective Study.
Clin J Sport Med
December 2024
Faculty of Medicine, University of Ondokuz Mayıs, Samsun, Türkiye.
Objectives: The clinical consequences of coronavirus infection in elite judokas with exercise-induced bronchoconstriction (EIB) are unclear. We aimed to determine potential respiratory function abnormalities and recovery in athletes with and without EIB after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
Design: Retrospective cohort study.
(FEV-FEV)/FVC: A Terminal-Airflow Variable for Airway Hyperresponsiveness and Inflammation Prediction in Patients With Symptoms Despite Preserved Spirometry.
J Allergy Clin Immunol Pract
January 2025
Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Background: Small-airway function assessment is crucial for asthma diagnosis and management. Abnormalities in terminal airflow deserve attention.
Objective: This study investigated whether (FEV-FEV)/FVC correlates with airway hyperresponsiveness (AHR) and inflammation in patients with preserved spirometry.
Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study.
ERJ Open Res
September 2024
Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy.
Introduction: Inhaled corticosteroid/formoterol fumarate (ICS/FF) as needed is recommended by the Global Initiative for Asthma (GINA) as sole therapy in adults with mild asthma, with low-dose maintenance ICS plus short-acting β-agonist (SABA) as an alternative. SABA alone is no longer recommended. Given these changes in recommendations, the observational PRIME study aimed to describe real-world treatment patterns in mild asthma in Europe.
View Article and Find Full Text PDFExercise-induced bronchoconstriction in adolescent recreational athletes: Potential screening strategies.
Pediatr Allergy Immunol
August 2024
Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Article Synopsis
- Intense physical exercise in adolescents can lead to exercise-induced bronchoconstriction (EIB), which affects 22% of athletes studied, with many being unaware of their condition.
- The study involved 327 adolescent athletes who underwent various tests, revealing links between EIB, asthma history, and atopy, with many EIB athletes not using inhalation therapy.
- Effective screening methods like questionnaires and lung function tests were highlighted, emphasizing the need for better detection of EIB, particularly in athletes exposed to air pollution.
Impact of Ongoing Treatment With Inhaled Corticosteroids During Specific Inhalation Challenges for Diagnosing Occupational Asthma.
J Allergy Clin Immunol Pract
November 2024
Chest Department, CIUSSS du Nord-de-l'île-de-Montréal, Montréal, QC, Canada; Chest Department, Université de Montréal, Montréal, QC, Canada. Electronic address:
Background: Specific inhalation challenge (SIC) tests are still the reference test for diagnosing sensitizer-induced occupational asthma (SIOA). The European Respiratory Society recommends the cessation of inhaled corticosteroids (ICS) 72 hours before SIC.
Objective: To assess the effect of an ongoing ICS treatment during SIC on the maximum fall in forced expiratory volume in 1 second (FEV), the change in methacholine provocative concentration of methacholine inducing a 20% fall in FEV (PC), and sputum eosinophil counts after exposure to the suspected agent.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!